Search Menu At Novartis, we are reimagining medicine About Novartis We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. Access We are committed to bringing more of our medicines to more people, no matter where they are. For all our new medicines, we will systematically integrate access strategies in how we research, develop and deliver globally. Research & Development We are exploring possibilities to cure disease, intervene earlier in chronic illnesses, and find ways to improve and extend people’s lives. Smart technology advances drug design Using the power of machine learning to help medical chemists design better molecules faster. Read More Research & development. It’s our heartbeat Our R&D teams are pushing the boundaries of science to discover and develop breakthrough treatments for patients. Learn More Toward regrowing cartilage Learn how wildlife regeneration is inspiring our efforts to regrow cartilage in patients with osteoarthritis. Read More Expanding a new digital healthcare solution More than 100,000 patients with heart failure in China are using our new AI-enabled platform, AI Nurse, to manage their condition and aim for better health. Read the Story Latest news Dec 02, 2021 Media Release Novartis R&D day spotlights attractive growth profile, underpinned by strong in-market brands, 20 potential high value pipeline assets, and technology platforms Nov 08, 2021 Media Update Novartis presents positive Phase III results for Cosentyx® in children with active enthesitis-related arthritis (ERA) and juvenile psoriatic arthritis (JPsA) at ACR 2021 Nov 08, 2021 Media Update Novartis announces new publication in Cephalalgia of data showcasing superior tolerability and efficacy of Aimovig® (erenumab) compared with topiramate in migraine prevention All News Novartis Financial Results – Q3 2021 Novartis announced the company’s financial results for the third quarter of 2021. Novartis COVID-19 Information Center Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources. The Novartis Commitment to Patients and Caregivers Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. People and Culture Novartis is building an Inspired, Curious and Unbossed culture. Live Magazine Live is the in-house magazine of Novartis which is now available in a digital format. Explore stories, podcasts and more from across the company. Environmental, Social and Governance (ESG) Building trust with society is a key pillar of the Novartis strategy. It defines our approach to managing key ESG topics including being part of the solution on pricing and access, addressing global health challenges, being a responsible citizen, and holding ourselves to high ethical standards. Learn More Novartis Navigate Topics Explore Companies © 2021 Novartis AG Terms of Use Privacy Contacts Cookie Settings Site Map Novartis Site Directory This site is intended for a global audience Your privacy is important for us. We use cookies to enhance your experience when visiting our websites: performance cookies show us how you use this website, functional cookies remember your preferences and targeting cookies help us to share content relevant to you. Select “Accept all” for giving your consent to all cookies, select “Cookie settings” for managing the different cookies or select “Reject all” for using only strictly necessary cookies. You can change your cookie settings at any point of time by pressing the cookie settings link on the website. Cookie Settings Reject all Accept all